A comprehensive view of vaccination/immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna refuses request by Chinese officials to share COVID-19 vaccine intellectual property, resulting in collapse of talks about potential supply deal with the country; Moderna reports it is still interested in supplying China with vaccines
Published: October 03, 2022 by FiercePharma
Global drug delivery system market projected to reach US$363.8B by 2030 with 6.1% CAGR growth from 2022 to 2030; growth driven by rising demand for biosimilars, vaccines, biologics, novel drug delivery systems
Published: October 03, 2022 by PR Newswire
Moderna names Juan Andres president of Strategic Partnerships and Enterprise Expansion to support the company’s growing pipeline of products; Jerh Collins, Ph.D., takes over Andres’ former job as chief of technical operations and quality officer
Published: September 30, 2022 by FiercePharma
WHO begins clinical trials in Columbia of nasal and oral COVID-19 vaccines in five cities; clinical trials also researching biologicals that can be used to treat patients hospitalized with COVID-19
Published: September 29, 2022 by CE Noticias Financieras
The unkindest jab of all, as South Africa sits idle with millions of COVID-19 vaccines; government has more than enough stock with extremely low public demand for vaccinations
Published: September 29, 2022 by Cape Times (South Africa)

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count